Richard Knight

Phase I dose-escalation study of AZD7762, a checkpoint kinase inhibitor, in combination with gemcitabine in US patients with advanced solid tumors

Edward A. Sausville, Patricia LoRusso, Michael A. Carducci et al. · Cancer Chemotherapy and Pharmacology · 2014 · 197 citations · Full text

Medicine, Oncology, Pharmacology +15

Cyclosporin A-induced changes in endogenous metabolites in rat urine: a metabonomic investigation using high field NMR spectroscopy, HPLC-TOF/MS and chemometrics

Eva M. Lenz, Jonathan Bright, Richard Knight et al. · Journal of Pharmaceutical and Biomedical Analysis · 2004 · 133 citations

Life Sciences, Pharmacology, Toxicology +16

A metabonomic investigation of the biochemical effects of mercuric chloride in the rat using 1H NMR and HPLC-TOF/MS: time dependant changes in the urinary profile of endogenous metabolites as a result of nephrotoxicity

Eva M. Lenz, Jonathan Bright, Richard Knight et al. · The Analyst · 2004 · 130 citations

Pharmacy, Biochemistry, Toxicology +17

Metabonomics with¹H-NMR spectroscopy and liquid chromatography-mass spectrometry applied to the investigation of metabolic changes caused by gentamicin-induced nephrotoxicity in the rat

Eva M. Lenz, Jonathan Bright, Richard Knight et al. · Biomarkers · 2005 · 129 citations

Medicine, Biochemistry, Toxicology +17

Wave and place fixed DPOAE maps of the human ear

Richard Knight, David T. Kemp · The Journal of the Acoustical Society of America · 2001 · 127 citations

Health Professions, Audiology, Neuroscience +9